Global Parkinsons Disease Therapeutics Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI284158
- March 18, 2019
- Global
- 102 pages
- QY Market Research
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Parkinsons Disease Therapeutics market.
Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Parkinsons Disease Therapeutics market."
Parkinsons disease is a type of progressive movement disorder, characterized by muscle rigidity, and tremors.
The global Parkinsons Disease Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Parkinsons Disease Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinsons Disease Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Abbvie
Biogen
Boehringer Ingelheim GmbH
F. Hoffman-La Roche
GlaxoSmithKline
H. Lundbeck A/S
Impax Labs
Newron Pharmaceuticals SpA
Novartis AG
Orion Corporation
Teva Pharmaceutical Industries Ltd.
UCB S.A.
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Segment by Application
Hospitals
Clinics
Others
Table of Contents
Executive Summary
1 Parkinson’s Disease Therapeutics Market Overview
1.1 Product Overview and Scope of Parkinson’s Disease Therapeutics
1.2 Parkinson’s Disease Therapeutics Segment by Type
1.2.1 Global Parkinson’s Disease Therapeutics Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Oral
1.2.3 Transdermal
1.2.4 Subcutaneous
1.2.5 Intestinal Infusion
1.3 Parkinson’s Disease Therapeutics Segment by Application
1.3.1 Parkinson’s Disease Therapeutics Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Parkinson’s Disease Therapeutics Market by Region
1.4.1 Global Parkinson’s Disease Therapeutics Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Parkinson’s Disease Therapeutics Market Size
1.5.1 Global Parkinson’s Disease Therapeutics Revenue (2014-2025)
1.5.2 Global Parkinson’s Disease Therapeutics Production (2014-2025)
2 Global Parkinson’s Disease Therapeutics Market Competition by Manufacturers
2.1 Global Parkinson’s Disease Therapeutics Production Market Share by Manufacturers (2014-2019)
2.2 Global Parkinson’s Disease Therapeutics Revenue Share by Manufacturers (2014-2019)
2.3 Global Parkinson’s Disease Therapeutics Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Parkinson’s Disease Therapeutics Production Sites, Area Served, Product Types
2.5 Parkinson’s Disease Therapeutics Market Competitive Situation and Trends
2.5.1 Parkinson’s Disease Therapeutics Market Concentration Rate
2.5.2 Parkinson’s Disease Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Parkinson’s Disease Therapeutics Production Market Share by Regions
3.1 Global Parkinson’s Disease Therapeutics Production Market Share by Regions
3.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Regions (2014-2019)
3.3 Global Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Parkinson’s Disease Therapeutics Production
3.4.1 North America Parkinson’s Disease ...
| read more...
Related Reports
